CZ-7, a new derivative of Claulansine F, promotes remyelination induced by cuprizone by enhancing myelin debris clearance.

The mechanism of demyelinating diseases is controversial, while demyelination and remyeliantion disorder is the acknowledged etiology and therapeutic target. Untill now, there is no efficient therapy for these diseases. CZ-7, a new derivative of Claulansine F, which has been reported before, were investigated its pro-remyelination effect and its associated mechanism in cuprizone (CPZ)-induced demyelination model. In this study, male C57BL/6 mice were subjected to CPZ (300 mg/kg) through intragastric gavage and were orally administered CZ-7 (20 mg/kg) meanwhile. The results of weight monitoring and behavioral testing showed that CZ-7 can significantly improve behavior dysfunction in the demyelinating mice. Luxol-fast blue (LFB) staining, myelin basic protein (MBP) immunostaining, transmission electron microscopy (TEM) and QPCR results indicated the therapeutic effect of CZ-7 on CPZ mice model. Furthermore, degraded myelin basic protein (dMBP) immunofluorescent staining and oil red O staining showed that CZ-7 contributed to the clearance of degraded myelin debris. More microglia displayed phagocytic shape assembled in corpus callosum (CC) and there was an active process of phagocytosis in microglia after CZ-7 treatment. Immunofluorescent staining and QPCR analysis revealed the M2-polarized phenotype switch of microglia in the process of myelin debris removel, which demostrated the microenvironment improvement of CZ-7. Moreover, immunofluorescent staining of NG2 and O4 demonstated that more oligodendrocyte precursor cells (OPCs) existed in CC after CZ-7 treatment. In conclusion, our results demonstrated CZ-7 has a potential therapeutic effect for MS and other demyelinating diseases through enhancing myelin debris clearance to improve the microenvironment.

• Publication year

  2020

• Venue

  Brain Research Bulletin

• Publication date

  2020-04-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainresbull.2020.03.017PMID 32289743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Repurposing of omeprazole for oligodendrocyte differentiation and remyelination.

  2019cited by this paper
• CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses

  2018cited by this paper
• Pyrano[3,2-a]carbazole alkaloids as effective agents against ischemic stroke in vitro and in vivo.

  2018cited by this paper
• Myelin injury in the central nervous system and Alzheimer's disease.

  2018cited by this paper
• Remyelination therapies: a new direction and challenge in multiple sclerosis

  2017cited by this paper
• Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.

  2017cited by this paper
• Electroacupuncture Promotes Remyelination after Cuprizone Treatment by Enhancing Myelin Debris Clearance

  2017cited by this paper
• Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease

  2017cited by this paper
• Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus‐Merzbacher Disease

  2016cited by this paper
• Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus‐Merzbacher Disease

  2016cited by this paper
• Claulansine F promoted the neuronal differentiation of neural stem and progenitor cells through Akt/GSK-3β/β-catenin pathway.

  2016cited by this paper
• Back on the scent: the olfactory system in CNS demyelinating diseases

  2016cited by this paper
• The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi-target effect.

  2016cited by this paper
• Promoting remyelination in multiple sclerosis: Current drugs and future prospects

  2015cited by this paper
• Stimulation of Monocytes, Macrophages, and Microglia by Amphotericin B and Macrophage Colony-Stimulating Factor Promotes Remyelination

  2015cited by this paper
• Inefficient clearance of myelin debris by microglia impairs remyelinating processes

  2015cited by this paper
• Remyelination in multiple sclerosis: Cellular mechanisms and novel therapeutic approaches

  2015cited by this paper
• Remyelination Therapy in Multiple Sclerosis

  2015cited by this paper
• Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.

  2015cited by this paper
• The sphingosine 1‐phosphate receptor agonist FTY720 is neuroprotective after cuprizone‐induced CNS demyelination

  2015cited by this paper
• IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity

  2015cited by this paper
• HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis

  2015cited by this paper
• Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

  2014cited by this paper
• Myelin proteomics: the past, the unexpected and the future

  2014cited by this paper
• Gender influence on schizophrenia‐relevant abnormalities in a cuprizone demyelination model

  2014cited by this paper
• Multiple Sclerosis: Current Knowledge and Future Outlook

  2014cited by this paper
• Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis

  2014cited by this paper
• DEMYELINATING DISORDERS ( DN BOURDETTE AND V YADAV , SECTION EDITORS ) Remyelination and Multiple Sclerosis : Therapeutic Approaches and Challenges

  2014cited by this paper
• A regenerative approach to the treatment of multiple sclerosis

  2013cited by this paper
• M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

  2013cited by this paper
• Claulansine F promotes neuritogenesis in PC12 cells via the ERK signaling pathway

  2013cited by this paper
• Claulansine F suppresses apoptosis induced by sodium nitroprusside in PC12 cells

  2013cited by this paper
• Promoting Remyelination in Multiple Sclerosis—Recent Advances

  2013cited by this paper
• Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.

  2013cited by this paper
• Rejuvenation of regeneration in the aging central nervous system.

  2012cited by this paper
• Identification of a microglia phenotype supportive of remyelination

  2012cited by this paper
• Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis

  2012cited by this paper
• Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

  2012cited by this paper
• Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

  2012cited by this paper
• Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during Experimental Autoimmune Encephalomyelitis

  2011cited by this paper
• Excess Circulating Alternatively Activated Myeloid (M2) Cells Accelerate ALS Progression While Inhibiting Experimental Autoimmune Encephalomyelitis

  2011cited by this paper
• Myelination and the trophic support of long axons

  2010cited by this paper
• Beneficial Effects of Minocycline on Cuprizone Induced Cortical Demyelination

  2010cited by this paper
• Multiple sclerosis: geoepidemiology, genetics and the environment.

  2010cited by this paper
• The cuprizone animal model: new insights into an old story

  2009cited by this paper
• Debris clearance by microglia: an essential link between degeneration and regeneration

  2008cited by this paper
• NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord.

  2008cited by this paper
• Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis

  2008cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• NG2‐positive cells generate A2B5‐positive oligodendrocyte precursor cells

  2007cited by this paper
• Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination.

  2007cited by this paper
• Complement levels and activity in the normal and LPS-injured lung.

  2007cited by this paper
• Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation

  2006cited by this paper
• Paraneoplastic syndromes affecting the nervous system.

  2006cited by this paper
• Mechanisms of CNS remyelination--the key to therapeutic advances.

  2005cited by this paper
• Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats

  2005cited by this paper
• Multiple sclerosis.

  2000cited by this paper
• Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

  1998cited by this paper
• Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens.

  1997cited by this paper
• Expression and Localization of Myelin Basic Protein in Oligodendrocytes and Transfected Fibroblasts

  1988cited by this paper
• Neuroscience and Biobehavioral Reviews Cellular and Molecular Neuropathology of the Cuprizone Mouse Model: Clinical Relevance for Multiple Sclerosis

  year unknowncited by this paper

• A review focuses on a neglected and controversial component of SCI: myelin debris

  2024cites this paper
• The paradoxical role of zinc on microglia.

  2023cites this paper
• Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis

  2023cites this paper
• CZK, a novel alkaloid derivative from Clausena lansium, alleviates ischemic stroke injury through Nrf2-mediated antioxidant effects

  2023cites this paper
• Drug-induced microglial phagocytosis in multiple sclerosis and experimental autoimmune encephalomyelitis and the underlying mechanisms

  2022cites this paper
• Neuromodulation of neurological disorders in a demyelination model: effect of a potassium channel inhibitor from Androctonus scorpion venom

  2022cites this paper
• The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis

  2022cites this paper
• Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.

  2022cites this paper
• Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice.

  2021cites this paper
• Role of microtubule dynamics in Wallerian degeneration and nerve regeneration after peripheral nerve injury

  2021cites this paper
• Rg1 exerts protective effect in CPZ-induced demyelination mouse model via inhibiting CXCL10-mediated glial response

  2021cites this paper
• Physical exercise modulates the astrocytes polarization, promotes myelin debris clearance and remyelination in chronic cerebral hypoperfusion rats.

  2021cites this paper